IRINOTECAN INTAS irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial

国家: 澳大利亚

语言: 英文

来源: Department of Health (Therapeutic Goods Administration)

有效成分:

irinotecan hydrochloride trihydrate, Quantity: 300 mg

可用日期:

Accord Healthcare Pty Ltd

药物剂型:

Injection, concentrated

组成:

Excipient Ingredients: hydrochloric acid; sodium hydroxide; lactic acid; water for injections; sorbitol

给药途径:

Intravenous Infusion

每包单位数:

1

处方类型:

(S4) Prescription Only Medicine

疗效迹象:

Irinotecan hydrochloride is indicated as a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum. Irinotecan hydrochloride is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

產品總結:

Visual Identification: A pale yellow clear solution; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

授权状态:

Registered

授权日期:

2020-03-05